Familial ovarian cancer: genes and variants
Explore variant evidence for Familial ovarian cancer across 3 analyzed proteins (BRIP1, RAD51C, RAD51D). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 44 variants of uncertain significance and 38 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial ovarian cancer
BRIP1: Fanconi anemia group J protein
It unwinds DNA structures and works with BRCA1 and the Fanconi-anemia pathway to repair damaged replication intermediates and interstrand crosslinks. Biallelic loss causes Fanconi anemia group J, while heterozygous loss-of-function variants increase ovarian-cancer risk.
2 ClinVar pathogenic / likely pathogenic and 36 uncertain variants in BRIP1 have source records linked to Familial ovarian cancer. Association strength is not clinical gene validity.
RAD51C: DNA repair protein RAD51 homolog 3
It participates in RAD51-paralog complexes that promote homologous-recombination repair and restart damaged replication forks. Heterozygous loss-of-function variants increase ovarian and breast-cancer risk, while biallelic variants can cause Fanconi anemia.
2 ClinVar pathogenic / likely pathogenic and 24 uncertain variants in RAD51C have source records linked to Familial ovarian cancer. Association strength is not clinical gene validity.
RAD51D: DNA repair protein RAD51 homolog 4
It supports RAD51-mediated homologous recombination and chromosome stability after DNA double-strand breaks. Heterozygous loss-of-function variants confer substantial ovarian-cancer risk and a more moderate increase in breast-cancer susceptibility.
1 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in RAD51D have source records linked to Familial ovarian cancer. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): PTEN.
ClinVar pathogenic and likely pathogenic variants linked to Familial ovarian cancer
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| RAD51D S207L | 207 | Pathogenic / likely pathogenic (★★) | |
| RAD51C L138F | 138 | Pathogenic / likely pathogenic (★★) | |
| RAD51C R258H | 258 | Pathogenic / likely pathogenic (★★) | |
| BRIP1 Q255H | 255 | Helicase ATP-binding | Pathogenic / likely pathogenic (★) |
| BRIP1 Q793H | 793 | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Hereditary breast ovarian cancer syndrome also has ClinVar records linked to RAD51C variants; they fall mostly in different places as the Familial ovarian cancer variants (10 pathogenic / likely pathogenic).
- Fanconi anemia complementation also has ClinVar records linked to RAD51C variants; they fall mostly in different places as the Familial ovarian cancer variants (4 pathogenic / likely pathogenic).
Diseases related to Familial ovarian cancer
- Ovarian cancer, also linked to BRIP1, RAD51C and RAD51D
- Hereditary breast ovarian cancer syndrome, also linked to BRIP1, RAD51C and RAD51D
- Gastric cancer, also linked to BRIP1, RAD51C and RAD51D
- Breast and/or ovarian cancer, also linked to BRIP1, RAD51C and RAD51D
- Fanconi anemia complementation, also linked to BRIP1 and RAD51C
- Fanconi anemia, also linked to BRIP1 and RAD51C
- Hereditary breast cancer, also linked to BRIP1
- Ovarian neoplasm, also linked to BRIP1
- RAD51C-related cancer predisposition, also linked to RAD51C
Frequently asked questions
Which genes have records linked to Familial ovarian cancer?
This view contains 3 analyzed proteins: BRIP1, RAD51C, RAD51D. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 44 variants of uncertain significance and 38 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 94 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center